Clinical Trial Update: Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating Babaodan for reducing tumor recurrence after curative resection of hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Babaodan

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Hepatocellular Carcinoma, Tumor Recurrence | Phase 4 | Status: UNKNOWN